tiprankstipranks
Trending News
More News >
Vivimed Labs Limited (IN:VIVIMEDLAB)
:VIVIMEDLAB
India Market

Vivimed Labs Limited (VIVIMEDLAB) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Vivimed Labs Limited has a market cap or net worth of $406.28M. The enterprise value is $4.18B.
Market Cap$406.28M
Enterprise Value$4.18B

Share Statistics

Vivimed Labs Limited has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding
Owned by Insiders
Owned by Institutions

Financial Efficiency

Vivimed Labs Limited’s return on equity (ROE) is -8.33 and return on invested capital (ROIC) is -28.96%.
Return on Equity (ROE)-8.33
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-28.96%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.19
Inventory Turnover3.51

Valuation Ratios

The current PE Ratio of Vivimed Labs Limited is -0.17. Vivimed Labs Limited’s PEG ratio is -0.18.
PE Ratio-0.17
PS Ratio
PB Ratio1.04
Price to Fair Value1.39
Price to FCF1.35
Price to Operating Cash Flow2.97
PEG Ratio-0.18

Income Statement

In the last 12 months, Vivimed Labs Limited had revenue of 1.87B and earned -3.29B in profits. Earnings per share was -39.62.
Revenue1.87B
Gross Profit-928.65M
Operating Income-1.22B
Pretax Income-3.31B
Net Income-3.29B
EBITDA-1.86B
Earnings Per Share (EPS)-39.62

Cash Flow

In the last 12 months, operating cash flow was 2.20B and capital expenditures 0.00, giving a free cash flow of 2.20B billion.
Operating Cash Flow2.20B
Free Cash Flow2.20B
Free Cash Flow per Share

Dividends & Yields

Vivimed Labs Limited pays an annual dividend of $0.4, resulting in a dividend yield of ―
Dividend Per Share$0.4
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta
52-Week Price Change
50-Day Moving Average
200-Day Moving Average
Relative Strength Index (RSI)
Average Volume (3m)

Important Dates

Vivimed Labs Limited upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateFeb 14, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateSep 19, 2018

Financial Position

Vivimed Labs Limited as a current ratio of 0.78, with Debt / Equity ratio of 966.53%
Current Ratio0.78
Quick Ratio0.60
Debt to Market Cap6.92
Net Debt to EBITDA-2.03
Interest Coverage Ratio-3.36

Taxes

In the past 12 months, Vivimed Labs Limited has paid -21.17M in taxes.
Income Tax-21.17M
Effective Tax Rate<0.01

Enterprise Valuation

Vivimed Labs Limited EV to EBITDA ratio is -2.32, with an EV/FCF ratio of 14.23.
EV to Sales2.31
EV to EBITDA-2.32
EV to Free Cash Flow14.23
EV to Operating Cash Flow31.28

Balance Sheet

Vivimed Labs Limited has $22.77M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -$22.77M billion.
Cash & Marketable Securities$22.77M
Total Debt₹0.00
Net Cash-$22.77M
Net Cash Per Share
Tangible Book Value Per Share-$14.26

Margins

Gross margin is -49.63%, with operating margin of -65.11%, and net profit margin of -175.59%.
Gross Margin-49.63%
Operating Margin-65.11%
Pretax Margin-176.72%
Net Profit Margin-175.59%
EBITDA Margin-99.37%
EBIT Margin-109.59%

Analyst Forecast

The average price target for Vivimed Labs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis